FAM98B

gene
On this page

Also known as FLJ38426

Summary

FAM98B (family with sequence similarity 98 member B, HGNC:26773) is a protein-coding gene on chromosome 15q14, encoding tRNA-splicing ligase complex subunit FAM98B (Q52LJ0). Accessory subunit of the tRNA-splicing ligase complex that acts by directly joining spliced tRNA halves to mature-sized tRNAs by incorporating the precursor-derived splice junction phosphate into the mature tRNA as a canonical 3’,5’-phosphodiester. It is a selective cancer dependency (DepMap: 33.6% of cell lines).

Enables identical protein binding activity and protein methyltransferase activity. Involved in positive regulation of cell population proliferation; positive regulation of gene expression; and protein methylation. Located in cytoplasm and nucleoplasm. Part of tRNA-splicing ligase complex.

Source: NCBI Gene 283742 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 71 total
  • Cancer dependency (DepMap): dependent in 33.6% of screened cell lines
  • MANE Select transcript: NM_173611

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26773
Approved symbolFAM98B
Namefamily with sequence similarity 98 member B
Location15q14
Locus typegene with protein product
StatusApproved
AliasesFLJ38426
Ensembl geneENSG00000171262
Ensembl biotypeprotein_coding
OMIM616142
Entrez283742

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron

ENST00000305752, ENST00000397609, ENST00000491535, ENST00000559431

RefSeq mRNA: 1 — MANE Select: NM_173611 NM_173611

CCDS: CCDS10047

Canonical transcript exons

ENST00000397609 — 8 exons

ExonStartEnd
ENSE000015293893848425538487710
ENSE000015293903848129238481459
ENSE000015294053845412738454232
ENSE000020986033847022738470405
ENSE000021040133847418238474298
ENSE000021264223847350538473585
ENSE000021269853846403238464177
ENSE000034646023846526938465403

Expression profiles

Bgee: expression breadth ubiquitous, 255 present calls, max score 96.08.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.1480 / max 527.0253, expressed in 1808 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
14586833.14801808

Top tissues by expression

258 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper arm skinUBERON:000426396.08gold quality
left ventricle myocardiumUBERON:000656695.65gold quality
cerebellar vermisUBERON:000472095.50gold quality
cardiac muscle of right atriumUBERON:000337995.22gold quality
thymusUBERON:000237094.76gold quality
ganglionic eminenceUBERON:000402394.67gold quality
ventricular zoneUBERON:000305394.13gold quality
myocardiumUBERON:000234994.06gold quality
germinal epithelium of ovaryUBERON:000130494.00gold quality
esophagus squamous epitheliumUBERON:000692093.81gold quality
saphenous veinUBERON:000731893.38gold quality
palpebral conjunctivaUBERON:000181293.35gold quality
ponsUBERON:000098893.25gold quality
visceral pleuraUBERON:000240193.18gold quality
kidney epitheliumUBERON:000481993.11gold quality
parietal pleuraUBERON:000240093.07gold quality
cortical plateUBERON:000534392.75gold quality
cauda epididymisUBERON:000436092.56gold quality
subthalamic nucleusUBERON:000190692.27gold quality
mucosa of paranasal sinusUBERON:000503092.20gold quality
pigmented layer of retinaUBERON:000178292.02gold quality
deltoidUBERON:000147691.88gold quality
vastus lateralisUBERON:000137991.81gold quality
dorsal plus ventral thalamusUBERON:000189791.72gold quality
nippleUBERON:000203091.70gold quality
penisUBERON:000098991.68gold quality
layer of synovial tissueUBERON:000761691.64gold quality
mammary ductUBERON:000176591.57gold quality
heart right ventricleUBERON:000208091.57gold quality
ventral tegmental areaUBERON:000269191.56gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

143 targeting FAM98B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4673100.0066.641490
HSA-MIR-3646100.0073.565283
HSA-MIR-8485100.0077.574731
HSA-MIR-3924100.0072.092394
HSA-MIR-186-5P99.9970.833707
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-1213699.9872.815713
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-60799.9773.625593
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-314899.9775.066478
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-548AB99.9571.313488
HSA-MIR-55999.9572.283609
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 33.6% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 2)

  • hCLE/C14orf166 associates with DDX1, HSPC117, and FAM98B in a novel transcription-dependent shuttling RNA-transporting complex. (PMID:24608264)
  • the two structural homologs FAM98A and FAM98B included in a novel complex with DDX1 and C14orf166 are required for PRMT1 expression in colorectal cancer cell lines (PMID:28040436)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriofam98bENSDARG00000060068
mus_musculusFam98bENSMUSG00000027349
rattus_norvegicusFam98bENSRNOG00000005366
rattus_norvegicusFam98b-ps1ENSRNOG00000069394
drosophila_melanogasterCG5913FBGN0039385
caenorhabditis_elegansWBGENE00044326

Paralogs (2): FAM98A (ENSG00000119812), FAM98C (ENSG00000130244)

Protein

Protein identifiers

tRNA-splicing ligase complex subunit FAM98BQ52LJ0 (reviewed: Q52LJ0)

All UniProt accessions (2): Q52LJ0, H0YNA1

UniProt curated annotations — full annotation on UniProt →

Function. Accessory subunit of the tRNA-splicing ligase complex that acts by directly joining spliced tRNA halves to mature-sized tRNAs by incorporating the precursor-derived splice junction phosphate into the mature tRNA as a canonical 3’,5’-phosphodiester. May act as an RNA ligase with broad substrate specificity and may function toward other RNAs. Could regulate the expression of PRMT1, a protein arginine N-methyltransferase.

Subunit / interactions. Homodimer. Component of the tRNA-splicing ligase core complex composed of the catalytic subunit RTCB and the accessory proteins DDX1, C2orf49/Ashwin/ASW, FAM98B and RTRAF/CGI-99. Interacts with FAM98A.

Subcellular location. Nucleus. Cytoplasm.

Tissue specificity. Expressed strongly in colorectal cancer tissues compared to wild-type colon samples (at protein level). Expressed strongly in colorectal cancer tissues compared to wild-type colon samples.

Miscellaneous. Dubious isoform due to intron retention.

Similarity. Belongs to the FAM98 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q52LJ0-22yes
Q52LJ0-11

RefSeq proteins (1): NP_775882* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR018797FAM98Family

Pfam: PF10239

UniProt features (7 total): compositionally biased region 2, splice variant 2, chain 1, region of interest 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q52LJ0-F175.110.39

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6784531tRNA processing in the nucleus

MSigDB gene sets: 161 (showing top): GOBP_TRNA_METABOLIC_PROCESS, chr15q14, GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION, GOBP_RNA_SPLICING, YRTCANNRCGC_UNKNOWN, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, GOBP_METHYLATION, GOBP_TRNA_PROCESSING, REACTOME_METABOLISM_OF_RNA, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY, GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS, ELK1_02

GO Biological Process (4): tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388), protein methylation (GO:0006479), positive regulation of cell population proliferation (GO:0008284), positive regulation of gene expression (GO:0010628)

GO Molecular Function (4): RNA binding (GO:0003723), protein methyltransferase activity (GO:0008276), identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), tRNA-splicing ligase complex (GO:0072669)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
tRNA processing1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
RNA splicing, via endonucleolytic cleavage and ligation1
tRNA processing1
protein alkylation1
macromolecule methylation1
cell population proliferation1
regulation of cell population proliferation1
positive regulation of cellular process1
gene expression1
regulation of gene expression1
positive regulation of macromolecule biosynthetic process1
nucleic acid binding1
methyltransferase activity1
catalytic activity, acting on a protein1
protein binding1
binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1
intracellular protein-containing complex1
catalytic complex1

Protein interactions and networks

STRING

1023 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM98BRTRAFQ9Y224996
FAM98BDDX1Q92499988
FAM98BRTCBQ9Y3I0950
FAM98BC2orf49Q9BVC5909
FAM98BZBTB8OSQ8IWT0640
FAM98BHNRNPDLO14979603
FAM98BCDIN1Q9Y2V0582
FAM98BKHSRPQ92945546
FAM98BUSP17L19D6RCP7507
FAM98BUSP17L15C9J2P7506
FAM98BPRMT1Q99873470
FAM98BELAVL4P26378456
FAM98BTRPT1Q86TN4448
FAM98BRTCAO00442430
FAM98BFBXW11Q9UKB1407

IntAct

76 interactions, top by confidence:

ABTypeScore
DDX1FAM98Bpsi-mi:“MI:0915”(physical association)0.670
RTRAFFAM98Bpsi-mi:“MI:0915”(physical association)0.560
MAPTKIF2Apsi-mi:“MI:0914”(association)0.530
NRBM47psi-mi:“MI:0914”(association)0.530
DDX1FAM98Cpsi-mi:“MI:0914”(association)0.530
FAM98BPRMT1psi-mi:“MI:0915”(physical association)0.400
FAM98BFAM98Bpsi-mi:“MI:0915”(physical association)0.400
FAM98AFAM98Bpsi-mi:“MI:0915”(physical association)0.400
JUNTPM3psi-mi:“MI:0914”(association)0.350
Xpo1IFT56psi-mi:“MI:0914”(association)0.350
ZBTB8OSFAM98Bpsi-mi:“MI:0914”(association)0.350
DLDNFKBIEpsi-mi:“MI:0914”(association)0.350
MAPTMEX3Apsi-mi:“MI:0914”(association)0.350
RTCBNSA2psi-mi:“MI:0914”(association)0.350
CAND1GTPBP10psi-mi:“MI:0914”(association)0.350
COPS5FBLL1psi-mi:“MI:0914”(association)0.350
CUL3PXDNLpsi-mi:“MI:0914”(association)0.350
LRRK2psi-mi:“MI:0914”(association)0.350
RTRAFDNAJB6psi-mi:“MI:0914”(association)0.350
PAK4SNRPEpsi-mi:“MI:0914”(association)0.350
NMRPL45psi-mi:“MI:0914”(association)0.350
NRBM47psi-mi:“MI:0914”(association)0.350
MAPTSHTN1psi-mi:“MI:0914”(association)0.350

BioGRID (156): FAM98B (Affinity Capture-RNA), FAM98B (Affinity Capture-RNA), FAM98B (Affinity Capture-MS), FAM98B (Affinity Capture-MS), C14orf166 (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation), FAM98B (Co-fractionation)

ESM2 similar proteins: A4IFB1, A6H7H1, A9ULY7, B1H1X4, B5DDX6, B5DF93, B5X165, D3Z8X7, O60308, P70501, Q05AW9, Q28HX4, Q3TC46, Q3TJZ6, Q52LJ0, Q5EA95, Q5FWT1, Q5R4R4, Q5R539, Q5R679, Q5R8Q4, Q5RHQ8, Q60520, Q62418, Q66I22, Q6A0A9, Q6DEZ2, Q6IVW0, Q80V31, Q80VD1, Q86TB9, Q8BH43, Q8BXG3, Q8CBY3, Q8CDG3, Q8CF97, Q8K2L8, Q8NCA5, Q8ND56, Q8R3P2

Diamond homologs: Q17RN3, Q3TJZ6, Q52LJ0, Q5FWT1, Q5R679, Q80VD1, Q8NCA5

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 65 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
tRNA processing in the nucleus521.9×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

71 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance64
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1025 predictions. Top by Δscore:

VariantEffectΔscore
15:38454230:GGG:Gdonor_gain1.0000
15:38454231:GG:Gdonor_gain1.0000
15:38454231:GGG:Gdonor_gain1.0000
15:38454231:GGGTG:Gdonor_loss1.0000
15:38454232:GG:Gdonor_gain1.0000
15:38454232:GGTG:Gdonor_loss1.0000
15:38454233:G:GGdonor_gain1.0000
15:38464111:C:Gdonor_gain1.0000
15:38464160:A:Tdonor_gain1.0000
15:38465265:A:AGacceptor_gain1.0000
15:38465265:AAAG:Aacceptor_gain1.0000
15:38465266:A:Gacceptor_gain1.0000
15:38465267:A:AGacceptor_gain1.0000
15:38465268:G:GGacceptor_gain1.0000
15:38465268:GGAA:Gacceptor_gain1.0000
15:38465400:CTAT:Cdonor_gain1.0000
15:38465400:CTATG:Cdonor_loss1.0000
15:38465401:TAT:Tdonor_gain1.0000
15:38465402:AT:Adonor_gain1.0000
15:38465403:TG:Tdonor_loss1.0000
15:38465404:G:GGdonor_gain1.0000
15:38465404:GTAAG:Gdonor_loss1.0000
15:38465405:TAAGT:Tdonor_loss1.0000
15:38465406:AAG:Adonor_loss1.0000
15:38470225:A:AGacceptor_gain1.0000
15:38470226:G:GAacceptor_gain1.0000
15:38470226:GT:Gacceptor_gain1.0000
15:38470226:GTA:Gacceptor_gain1.0000
15:38470226:GTATT:Gacceptor_gain1.0000
15:38470401:CAAAG:Cdonor_loss1.0000

AlphaMissense

2749 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:38474281:T:AW238R1.000
15:38474281:T:CW238R1.000
15:38484280:G:CR308T1.000
15:38484280:G:TR308M1.000
15:38484281:G:CR308S1.000
15:38484281:G:TR308S1.000
15:38484283:G:AG309E1.000
15:38484330:T:AW325R1.000
15:38484330:T:CW325R1.000
15:38484332:G:CW325C1.000
15:38484332:G:TW325C1.000
15:38474230:C:AR221S0.999
15:38474231:G:CR221P0.999
15:38474234:G:CR222P0.999
15:38474272:T:CS235P0.999
15:38474275:T:CF236L0.999
15:38474277:T:AF236L0.999
15:38474277:T:GF236L0.999
15:38474283:G:CW238C0.999
15:38474283:G:TW238C0.999
15:38481332:G:CR257P0.999
15:38484262:T:CM302T0.999
15:38484276:G:CD307H0.999
15:38484277:A:TD307V0.999
15:38484282:G:AG309R0.999
15:38484282:G:CG309R0.999
15:38484283:G:TG309V0.999
15:38484285:G:CG310R0.999
15:38484322:T:CM322T0.999
15:38484322:T:GM322R0.999

dbSNP variants (sampled 300 via entrez): RS1000148454 (15:38477550 C>T), RS1000252264 (15:38483092 T>C), RS1000283317 (15:38482739 A>T), RS1000473904 (15:38459450 CT>C), RS1000504963 (15:38462812 A>G,T), RS1000598571 (15:38475682 A>G), RS1000635545 (15:38468830 C>T), RS1000665215 (15:38468514 T>C), RS1000752458 (15:38475955 C>T), RS1000864789 (15:38464448 T>A,C), RS1001002887 (15:38457123 A>G), RS1001057025 (15:38476864 G>A,T), RS1001117066 (15:38456818 A>G), RS1001126439 (15:38469638 A>G), RS1001135819 (15:38477361 G>A)

Disease associations

OMIM: gene MIM:616142 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002211_9Psychosis (atypical)4.000000e-06
GCST002463_20Systemic lupus erythematosus1.000000e-14

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, increases expression2
sodium arseniteincreases abundance, increases expression, increases activity2
Air Pollutantsaffects expression, increases abundance, decreases expression2
Benzo(a)pyreneaffects methylation, increases expression2
aristolochic acid Idecreases expression1
FR900359increases phosphorylation1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, increases activity, increases expression1
beta-lapachoneincreases expression1
methylparabendecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608increases reaction, affects binding1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrinedecreases expression1
LDN 193189affects cotreatment, increases expression1
Arsenicincreases abundance, increases expression1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Ivermectindecreases expression1
Methyl Methanesulfonatedecreases expression1
Ozoneaffects expression, increases abundance1
Quercetindecreases expression1
Ribonucleotidesaffects binding1
Tetrachlorodibenzodioxinaffects expression1
Tretinoindecreases expression1
Valproic Aciddecreases expression1
Vanadatesdecreases expression1
Aflatoxin M1decreases expression1
Antirheumatic Agentsincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): psychotic disorder